Apeiron Investment Group Ltd. has filed 17 insider transactions across 3 companies since February 2023.
Most recent transaction: a transaction of 147950 shares of Atai Beckley N.V. ($ATAI) on September 30, 2025.
Activity breakdown: 5 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 30, 2025 | Atai Beckley N.V. | $ATAI | Apeiron Investment Group Ltd. | Not found | C | Convertible Notes | 147950 | $0.00 | 0.0000 | 198,306,455 | 100.00% | 0.07% |
| Sept. 30, 2025 | Atai Beckley N.V. | $ATAI | Apeiron Investment Group Ltd. | Not found | C | Common Shares | 2367200 | $0.00 | 55,211,716.0000 | 198,306,455 | 4.48% | 1.19% |
| Aug. 14, 2025 | Atai Beckley N.V. | $ATAI | Apeiron Investment Group Ltd. | Not found | P | Common Shares | 8675799 | $2.19 | 52,844,516.0000 | 198,306,455 | 19.64% | 4.37% |
| March 24, 2025 | Atai Beckley N.V. | $ATAI | Apeiron Investment Group Ltd. | Not found | P | Common Shares | 1800000 | $1.40 | 44,168,717.0000 | 198,306,455 | 4.25% | 0.91% |
| Feb. 14, 2025 | Atai Beckley N.V. | $ATAI | Apeiron Investment Group Ltd. | Not found | P | Common Shares | 10835718 | $2.10 | 42,354,517.0000 | 0 | 34.38% | 0.00% |
| April 15, 2024 | Atai Beckley N.V. | $ATAI | Apeiron Investment Group Ltd. | Not found | J | Convertible Notes | 147950 | $0.00 | 147,950.0000 | 0 | 9999.99% | 0.00% |
| April 15, 2024 | Atai Beckley N.V. | $ATAI | Apeiron Investment Group Ltd. | Not found | J | Convertible Notes | 147950 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 6, 2024 | Alto Neuroscience, Inc. | $ANRO | Apeiron Investment Group Ltd. | Not found | C | Common Stock | 251881 | $0.00 | 926,539.0000 | 0 | 37.33% | 0.00% |
| Feb. 6, 2024 | Alto Neuroscience, Inc. | $ANRO | Apeiron Investment Group Ltd. | Not found | C | Common Stock | 674658 | $0.00 | 926,539.0000 | 0 | 267.85% | 0.00% |
| Feb. 6, 2024 | Alto Neuroscience, Inc. | $ANRO | Apeiron Investment Group Ltd. | Not found | C | Warrants to Purchase Series A Preferred Stock | 444561 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 6, 2024 | Alto Neuroscience, Inc. | $ANRO | Apeiron Investment Group Ltd. | Not found | C | Series A Preferred Stock | 406072 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 6, 2024 | Alto Neuroscience, Inc. | $ANRO | Apeiron Investment Group Ltd. | Not found | C | Series A Preferred Stock | 1063918 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 6, 2024 | Alto Neuroscience, Inc. | $ANRO | Apeiron Investment Group Ltd. | Not found | C | Series B Preferred Stock | 416665 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 1, 2023 | Sensei Biotherapeutics, Inc. | $SNSE | Apeiron Investment Group Ltd. | TenPercentOwner | S | Common Stock | 2485923 | $1.58 | 0.0000 | 0 | 100.00% | 0.00% |
| June 1, 2023 | Sensei Biotherapeutics, Inc. | $SNSE | Apeiron Investment Group Ltd. | TenPercentOwner | S | Common Stock | 955738 | $1.58 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 23, 2023 | Sensei Biotherapeutics, Inc. | $SNSE | Apeiron Investment Group Ltd. | TenPercentOwner | P | Common Stock | 1100 | $1.62 | 3,440,561.0000 | 0 | 0.03% | 0.00% |
| Feb. 23, 2023 | Sensei Biotherapeutics, Inc. | $SNSE | Apeiron Investment Group Ltd. | TenPercentOwner | P | Common Stock | 1100 | $1.60 | 3,441,661.0000 | 0 | 0.03% | 0.00% |